Recent Finacing
Recent Raise
ExcepGen develops nucleic acid therapeutics that co-encode a "shield" protein with DNA or RNA cargo to modulate cellular immune signaling and improve tolerability and delivery of genetic medicines.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at ExcepGen.
